PDS Biotechnology Corp Quarterly Operating Income (Loss) in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
PDS Biotechnology Corp quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q2 2024.
  • PDS Biotechnology Corp Operating Income (Loss) for the quarter ending June 30, 2024 was -$8.68M, a 31.6% increase year-over-year.
  • PDS Biotechnology Corp Operating Income (Loss) for the twelve months ending June 30, 2024 was -$39.7M, a 17.7% increase year-over-year.
  • PDS Biotechnology Corp annual Operating Income (Loss) for 2023 was -$43M, a 3.29% decline from 2022.
  • PDS Biotechnology Corp annual Operating Income (Loss) for 2022 was -$41.7M, a 94.4% decline from 2021.
  • PDS Biotechnology Corp annual Operating Income (Loss) for 2021 was -$21.4M, a 43.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$39.7M -$8.68M +$4.01M +31.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$43.7M -$10.1M -$675K -7.17% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$43M -$10.4M +$8.41M +44.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$51.5M -$10.5M -$3.24M -44.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$48.2M -$12.7M -$5.6M -79% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$42.6M -$9.42M -$943K -11.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$41.7M -$18.8M -$12.5M -198% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$29.2M -$7.28M -$317K -4.55% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$28.9M -$7.09M -$1.99M -38.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$26.9M -$8.48M -$5.43M -178% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$21.4M -$6.32M -$2.29M -57% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$19.1M -$6.96M -$3.06M -78.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$16.1M -$5.11M -$2.17M -73.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$13.9M -$3.05M +$983K +24.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$14.9M -$4.03M +$1.95M +32.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$16.9M -$3.91M +$1.94M +33.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$18.8M -$2.94M +$1.33M +31.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$20.1M -$4.03M +$904K +18.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$21M -$5.98M -$4.35M -266% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 -$16.7M -$5.85M -$5.14M -723% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$11.5M -$4.27M -$3.7M -653% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$7.85M -$4.94M -$4.2M -570% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$3.65M -$1.63M +$14.5M +89.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 -$18.1M -$710K +$10.2M +93.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$28.3M -$567K +$12.6M +95.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$40.9M -$737K +$11.1M +93.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$52M -$16.1M -$5.19M -47.4% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-01
Q3 2017 -$46.8M -$10.9M -$626K -6.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 -$46.2M -$13.1M -$3.88M -41.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 -$42.3M -$11.8M -$2.76M -30.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q4 2016 -$39.5M -$10.9M -$2.07M -23.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$37.4M -$10.3M -$1.79M -21.1% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 -$35.7M -$9.26M -$4.3M -86.7% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 -$31.3M -$9.03M -$4.85M -116% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 -$26.5M -$8.87M -$4.85M -121% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-02
Q3 2015 -$21.6M -$8.49M -$4.93M -138% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-02
Q2 2015 -$16.7M -$4.96M -$1.81M -57.4% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-02
Q1 2015 -$14.9M -$4.18M -$1.72M -69.7% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-02
Q4 2014 -$13.2M -$4.02M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-08
Q3 2014 -$3.56M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-08
Q2 2014 -$3.15M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-08
Q1 2014 -$2.47M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.